Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 368

Similar articles for PubMed (Select 22768077)

1.

Prevention of birch pollen-related food allergy by mucosal treatment with multi-allergen-chimers in mice.

Hoflehner E, Hufnagl K, Schabussova I, Jasinska J, Hoffmann-Sommergruber K, Bohle B, Maizels RM, Wiedermann U.

PLoS One. 2012;7(6):e39409. doi: 10.1371/journal.pone.0039409. Epub 2012 Jun 29.

2.

Intranasal treatment with a recombinant hypoallergenic derivative of the major birch pollen allergen Bet v 1 prevents allergic sensitization and airway inflammation in mice.

Wiedermann U, Herz U, Baier K, Vrtala S, Neuhaus-Steinmetz U, Bohle B, Dekan G, Renz H, Ebner C, Valenta R, Kraft D.

Int Arch Allergy Immunol. 2001 Sep;126(1):68-77.

PMID:
11641608
3.

A recombinant allergen chimer as novel mucosal vaccine candidate for prevention of multi-sensitivities.

Wild C, Wallner M, Hufnagl K, Fuchs H, Hoffmann-Sommergruber K, Breiteneder H, Scheiner O, Ferreira F, Wiedermann U.

Allergy. 2007 Jan;62(1):33-41.

PMID:
17156339
4.

Kinetics, cross-reactivity, and specificity of Bet v 1-specific IgG4 antibodies induced by immunotherapy with birch pollen.

Subbarayal B, Schiller D, Möbs C, de Jong NW, Ebner C, Reider N, Bartel D, Lidholm J, Pfützner W, Gerth van Wijk R, Vieths S, Bohle B.

Allergy. 2013 Nov;68(11):1377-86. doi: 10.1111/all.12236. Epub 2013 Sep 21.

PMID:
24053565
5.

Oral exposure to Mal d 1 affects the immune response in patients with birch pollen allergy.

Geroldinger-Simic M, Kinaciyan T, Nagl B, Baumgartner-Durchschlag U, Huber H, Ebner C, Lidholm J, Bartel D, Vieths S, Jahn-Schmid B, Bohle B.

J Allergy Clin Immunol. 2013 Jan;131(1):94-102. doi: 10.1016/j.jaci.2012.06.039. Epub 2012 Aug 24.

PMID:
22921871
6.

In vitro analysis of birch-pollen-associated food allergy by use of recombinant allergens in the basophil activation test.

Erdmann SM, Sachs B, Schmidt A, Merk HF, Scheiner O, Moll-Slodowy S, Sauer I, Kwiecien R, Maderegger B, Hoffmann-Sommergruber K.

Int Arch Allergy Immunol. 2005 Mar;136(3):230-8. Epub 2005 Feb 15.

PMID:
15713985
7.

A nonallergenic birch pollen allergy vaccine consisting of hepatitis PreS-fused Bet v 1 peptides focuses blocking IgG toward IgE epitopes and shifts immune responses to a tolerogenic and Th1 phenotype.

Marth K, Breyer I, Focke-Tejkl M, Blatt K, Shamji MH, Layhadi J, Gieras A, Swoboda I, Zafred D, Keller W, Valent P, Durham SR, Valenta R.

J Immunol. 2013 Apr 1;190(7):3068-78. doi: 10.4049/jimmunol.1202441. Epub 2013 Feb 25.

8.

Mucosal co-application of lactic acid bacteria and allergen induces counter-regulatory immune responses in a murine model of birch pollen allergy.

Repa A, Grangette C, Daniel C, Hochreiter R, Hoffmann-Sommergruber K, Thalhamer J, Kraft D, Breiteneder H, Mercenier A, Wiedermann U.

Vaccine. 2003 Dec 8;22(1):87-95.

PMID:
14604575
9.

Cor a 1-reactive T cells and IgE are predominantly cross-reactive to Bet v 1 in patients with birch pollen-associated food allergy to hazelnut.

Hofmann C, Scheurer S, Rost K, Graulich E, Jamin A, Foetisch K, Saloga J, Vieths S, Steinbrink K, Adler HS.

J Allergy Clin Immunol. 2013 May;131(5):1384-92.e6. doi: 10.1016/j.jaci.2012.10.037. Epub 2012 Dec 11.

PMID:
23246018
10.

Oesophagostomum dentatum extract modulates T cell-dependent immune responses to bystander antigens and prevents the development of allergy in mice.

Schabussova I, Ul-Haq O, Hoflehner E, Akgün J, Wagner A, Loupal G, Joachim A, Ruttkowski B, Maizels RM, Wiedermann U.

PLoS One. 2013 Jul 2;8(7):e67544. doi: 10.1371/journal.pone.0067544. Print 2013.

11.
12.

Characterization of the protective and therapeutic efficiency of a DNA vaccine encoding the major birch pollen allergen Bet v 1a.

Hartl A, Hochreiter R, Stepanoska T, Ferreira F, Thalhamer J.

Allergy. 2004 Jan;59(1):65-73.

PMID:
14674936
13.

Bet v 1142-156 is the dominant T-cell epitope of the major birch pollen allergen and important for cross-reactivity with Bet v 1-related food allergens.

Jahn-Schmid B, Radakovics A, Lüttkopf D, Scheurer S, Vieths S, Ebner C, Bohle B.

J Allergy Clin Immunol. 2005 Jul;116(1):213-9.

PMID:
15990797
14.

Airway inflammation induced after allergic poly-sensitization can be prevented by mucosal but not by systemic administration of poly-peptides.

Hufnagl K, Focke M, Gruber F, Hufnagl P, Loupal G, Scheiner O, Wiedermann U.

Clin Exp Allergy. 2008 Jul;38(7):1192-202. doi: 10.1111/j.1365-2222.2008.02992.x. Epub 2008 May 6.

PMID:
18462454
15.

Bet v 1, the major birch pollen allergen, initiates sensitization to Api g 1, the major allergen in celery: evidence at the T cell level.

Bohle B, Radakovics A, Jahn-Schmid B, Hoffmann-Sommergruber K, Fischer GF, Ebner C.

Eur J Immunol. 2003 Dec;33(12):3303-10.

PMID:
14635038
16.

Birch pollen immunotherapy results in long-term loss of Bet v 1-specific TH2 responses, transient TR1 activation, and synthesis of IgE-blocking antibodies.

Möbs C, Ipsen H, Mayer L, Slotosch C, Petersen A, Würtzen PA, Hertl M, Pfützner W.

J Allergy Clin Immunol. 2012 Nov;130(5):1108-1116.e6. doi: 10.1016/j.jaci.2012.07.056. Epub 2012 Sep 27.

PMID:
23021882
17.

Immunoregulation by Toxoplasma gondii infection prevents allergic immune responses in mice.

Wagner A, Förster-Waldl E, Garner-Spitzer E, Schabussova I, Kundi M, Pollak A, Scheiner O, Joachim A, Wiedermann U.

Int J Parasitol. 2009 Mar;39(4):465-72. doi: 10.1016/j.ijpara.2008.09.003. Epub 2008 Oct 2.

PMID:
18938169
18.

Soybean allergy in patients allergic to birch pollen: clinical investigation and molecular characterization of allergens.

Mittag D, Vieths S, Vogel L, Becker WM, Rihs HP, Helbling A, Wüthrich B, Ballmer-Weber BK.

J Allergy Clin Immunol. 2004 Jan;113(1):148-54.

PMID:
14713921
19.

Bet v 1--a Trojan horse for small ligands boosting allergic sensitization?

Asam C, Batista AL, Moraes AH, de Paula VS, Almeida FC, Aglas L, Kitzmüller C, Bohle B, Ebner C, Ferreira F, Wallner M, Valente AP.

Clin Exp Allergy. 2014 Aug;44(8):1083-93. doi: 10.1111/cea.12361.

PMID:
24979350
20.

T cell epitope-containing hypoallergenic recombinant fragments of the major birch pollen allergen, Bet v 1, induce blocking antibodies.

Vrtala S, Akdis CA, Budak F, Akdis M, Blaser K, Kraft D, Valenta R.

J Immunol. 2000 Dec 1;165(11):6653-9.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk